THE DEAL, AT A GLANCE
From the announcementKesmalea Therapeutics
01Who is involvedBacked by 4BIO CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedKesmalea Therapeutics raised Series A, announced 2026-11-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersKesmalea Therapeutics' recorded Series A sits within a broad Unclassified funding pool, but the deal record contains conflicting financing amounts: $0M in the verified…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Kesmalea Therapeutics · Financing Record
Explore source-linked visual explanations for Kesmalea Therapeutics. Unsupported claims are withheld while source review continues.
Record 15712 · Recorded date: 2026-11-10
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →